Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study
Depressive Symptome sind mit schlechter Prognose und niedrigerer pathologischer Komplettremission bei triple-negativem Brustkrebs verbunden: eine einzentrumige retrospektive Studie
Frontiers in Oncology · 11.11.2026 · 16
DOI: 10.3389/fonc.2026.1996522 ↗Auf einen Blick
Bei 4.060 Patient:innen mit triple-negativem Brustkrebs waren moderate/schwere depressive Symptome mit schlechterem Überleben und niedrigerer pCR verbunden. Die NHANES-Analyse zeigte nur einen Zusammenhang mit Selbstangabe einer Krebserkrankung.
Fragestellung
Sind depressive Symptome bei triple-negativem Brustkrebs mit Überleben und Ansprechen auf neoadjuvante Chemotherapie assoziiert?
Methode
Einzentrumige retrospektive Studie mit 4.060 TNBC-Patient:innen; PHQ-9 zu Baseline; Cox- und logistische Regressionen. Zusätzliche explorative Querschnittsanalyse in NHANES 2009–2018.
Ergebnisse
Bei 3.878 Patient:innen ohne Basismetastasen waren moderate/schwere Symptome mit höherem Risiko für OS (HR 1,626; 95 %-KI 1,301–2,033) und DFS (HR 1,439; 95 %-KI 1,170–1,770) verbunden. pCR: 26,34 % vs. 36,18 %; OR 0,668 (95 %-KI 0,474–0,930).
Einschränkungen
Retrospektiv; mögliche Reverse Causation; unberücksichtigte Behandlungsgabe; keine kausale Aussage.
Schlussfolgerung der Autor:innen
Moderate/schwere depressive Symptome zu Baseline waren in dieser retrospektiven TNBC-Kohorte mit schlechterem Überleben und niedrigerer pCR verbunden.
Kernaussagen
- OS: HR 1,626; 95 %-KI 1,301–2,033
- pCR: 26,34 % vs. 36,18 %; OR 0,668
- NHANES: Zusammenhang mit Selbstangabe von Krebs, Brustkrebs nicht signifikant
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 11.11.2026. Verfasst von Hailin Yang und 6 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Depressive symptoms are common in patients with cancer, but their associations with survival and treatment response in triple-negative breast cancer (TNBC) remain uncertain.
Methods
This single-center retrospective study screened 19,335 patients with breast cancer treated during 2015–2025 and included 4,060 patients with TNBC. A single baseline Patient Health Questionnaire-9 (PHQ-9) assessment classified patients into normal/mild (score <10; n = 3,666) and moderate/severe (score ≥10; n = 394) symptom groups. Survival analyses included 3,878 patients without baseline distant metastasis; pathological complete response (pCR) analyses included 1,689 neoadjuvant chemotherapy (NACT) recipients with available response data. Cox and logistic regression models adjusted for recorded clinicopathological variables. An exploratory cross-sectional analysis of NHANES 2009–2018 was conducted separately.
Results
In the TNBC cohort, moderate/severe baseline depressive symptoms were associated with differences in T-stage and Ki-67 distributions and a higher frequency of baseline distant metastasis. N-stage distributions did not differ significantly (P = 0.059). Among patients without baseline distant metastasis, adjusted hazard ratios were 1.626 for overall survival (OS; 95% CI: 1.301–2.033; P < 0.001) and 1.439 for disease-free survival (DFS; 95% CI: 1.170–1.770; P < 0.001). The pCR rate was 26.34% in the moderate/severe group versus 36.18% in the normal/mild group (adjusted OR = 0.668; 95% CI: 0.474–0.930; P = 0.018). In NHANES, depressive symptoms were associated with higher odds of a self-reported history of any cancer (OR = 1.41; 95% CI: 1.19–1.67), whereas the breast cancer estimate was not statistically significant (OR = 1.43; 95% CI: 0.97–2.05).
Conclusion
Moderate/severe baseline depressive symptoms were associated with worse survival and lower pCR in this retrospective TNBC cohort. Reverse causation and unaccounted-for treatment delivery limit interpretation. These findings do not establish a causal effect or the prognostic utility of PHQ-9 beyond established factors. Prospective studies with repeated symptom assessments and detailed treatment records are needed.
Zitieren
APA
Yang, H., Wang, X., Chen, K., Hu, X., Li, H., Tang, L., & Liu, S. (2026). Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1996522
Vancouver
Yang H, Wang X, Chen K, Hu X, Li H, Tang L, et al. Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1996522
BibTeX
@article{Yang2026,
author = {Yang, Hailin and Wang, Xuanyi and Chen, Kunxia and Hu, Xiaolu and Li, Hanzhi and Tang, Lingfeng and Liu, Shengchun},
title = {Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1996522}
}
EUVIMED